Clinical utility gene card: for incontinentia pigmenti

  • 119 Accesses

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Scheuerle AE, Ursini MV. Incontinentia pigmenti. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.

  2. 2.

    Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–224.

  3. 3.

    Nelson DL. NEMO, NF kappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev. 2006;16:282–8.

  4. 4.

    Fusco F, Fimiani G, Tadini G, Michele D, Ursini MV. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients. J Am Acad Dermatol. 2007;56:264–7.

  5. 5.

    Fusco F, Conte MI, Diociaiuti A, Bigoni S, Branda MF, Ferlini A, et al. Unusual father-to-daughter transmission of incontinentia pigmenti due to mosaicism in IP males. Pediatrics. 2017;140:e20162950.

  6. 6.

    Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, et al. International IP Consortium. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet. 2001;69:1210–7.

  7. 7.

    Fusco F, Pescatore A, Conte MI, Mirabelli P, Paciolla M, Esposito E, et al. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation. Int Rev Immunol. 2015;34:44.

  8. 8.

    Fusco F, Pescatore A, Bal E, Ghoul A, Paciolla M, Lioi MB, et al. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Hum Mutat. 2008;29:595–604.

  9. 9.

    Conte MI, Pescatore A, Paciolla M, Esposito E, Miano MG, Lioi MB, et al. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Hum Mutat. 2014;35:165–77.

  10. 10.

    Bal E, Laplantine E, Hamel Y, Dubosclard V, Boisson B, Pescatore A, et al. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti. J Allergy Clin Immunol. 2017;140:1671–82.

  11. 11.

    Hull S, Arno G, Thomson P, Mutch S, Webster AR, Rai H, et al. Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti. Am J Med Genet A. 2015;167:1601–4.

  12. 12.

    Boisson B, Honda Y, Ajiro M, Bustamante J, Bendavid M, Gennery AR, et al. Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency. J Clin Invest. 2018;124011.

  13. 13.

    Fusco F, Paciolla M, Pescatore A, Lioi MB, Ayuso C, Faravelli F, et al. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with Incontinentia Pigmenti. Hum Mutat. 2009;30:1284–91.

  14. 14.

    Fusco F, Paciolla M, Napolitano F, Pescatore A, D’Addario I, Bal E, et al. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms. Hum Mol Genet. 2012;21:1260–71.

  15. 15.

    Fusco F, Pescatore A, Steffann J, Royer G, Bonnefont JP, Ursini MV Clinical Utility Gene Card for: incontinentia pigmenti. Eur J Hum Genet. 2013;21.

  16. 16.

    Orphanet Report Series—Prevalence of rare diseases: Bibliographic data—June 2018—Number 1.

  17. 17.

    Donnai D. Incontinentia pigmenti. In: Cassidy S, Allanson JE, (eds.). Management of genetic syndromes. 2nd edn. Hoboken, NJ: Wiley-Liss; 2005. p. 309–14.

  18. 18.

    Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53–9.

  19. 19.

    Minic S, Trpinac D, Obradovic M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85:536–42.

  20. 20.

    Hadj-Rabia S, Froidevaux D, Bodak N, Hamel-Teillac D, Smahi A, Touil Y, et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol. 2003;139:1163–70.

  21. 21.

    Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum Mol Genet. 2004;13:1763–73.

  22. 22.

    Pizzamiglio MR, Piccardi L, Bianchini F, Canzano L, Palermo L, Fusco F, et al. Incontinentia pigmenti: learning disabilities are a fundamental hallmark of the disease. PLoS One 2014;9:e87771. eCollection 2014.

  23. 23.

    Meuwissen ME, Mancini GM. Neurological findings in incontinentia pigmenti: a review. Eur J Med Genet. 2012;55:323–31.

Download references


We would like to thank the patients, and their families and physicians. We are also grateful to the Italian Incontinentia Pigmenti Association (www.incontinentiapigmenti. it), the French Incontinentia Pigmenti Association (, and the Incontinentia Pigmenti International Foundation (

This work was supported by the Incontinentia Pigmenti International Foundation (IPIF,, the Italian Incontinentia Pigmenti Association (IPASSI,, the French Incontinentia Pigmenti Association (FIP,, by CNR-DSB Progetto Bandiera “InterOmics” grant to Fusco and Ursini and by the InBioMed project grant (ARS01_01081_ PON/PNR 2015-20 MIUR to MB Lioi and to MV Ursini).

We would like to thank Ahmed EL-Sharkawy for revising the paper.

Author information

Correspondence to Matilde Valeria Ursini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fusco, F., Pescatore, A., Steffann, J. et al. Clinical utility gene card: for incontinentia pigmenti. Eur J Hum Genet 27, 1894–1900 (2019).

Download citation